$2.610
+0.104 (+3.98%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
RCKT-Prognose durch Analyse ähnlicher Charts
Alphio's RCKT stock price prediction model matches the current Rocket Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.65 (+1.50%). The 1-week path is $2.25 (-13.97%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Rocket Pharmaceuticals Inc-Aktien kaufen?
Rocket Pharmaceuticals Inc appears to be a good buy right now due to its recent upgrade by Needham to a Buy rating with a price target of $9, suggesting a potential upside of approximately 150% from the current price of $2.47. Additionally, the stock has shown a positive momentum with a 5-day change of +8.33%, indicating increasing investor interest. The main risk to consider is the company's forward P/E ratio, which is currently at 0, reflecting uncertainty in future earnings projections.
RCKT schloss am Wednesday bei $2.61, nachdem der Kurs +3.98% gestiegen ist
Rocket Pharmaceuticals Inc (RCKT) last closed at $2.6099999, gaining +3.98%. These facts feed the 1-day and 1-week RCKT price prediction above.
Analystenkonsens
Rocket Pharmaceuticals Inc (RCKT): 1 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Rocket Pharmaceuticals Inc (RCKT) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf RCKT am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für RCKT
Historically the probability of a positive November return for RCKT is 0.00%. March offers the highest probability of a positive month at 34.92%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.